[Form 4] PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Insider Trading Activity
Rhea-AI Filing Summary
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. director Christopher Gibson reported equity awards connected to his election to the Board. On March 3, 2026, he received stock options for 73,087 shares at an exercise price of $0.00 and a grant of 53,913 shares of common stock represented by restricted stock units.
The RSUs vest in three equal annual installments on March 3, 2027, 2028, and 2029, conditioned on continued Board service. One‑third of the stock options vest on March 3, 2027, with the remaining options vesting in equal monthly installments over the following 24 months while he remains a director.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 53,913 shares
Net Buy
2 txns
Insider
Gibson Christopher
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 73,087 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 53,913 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 73,087 shares (Direct);
Common Stock — 53,913 shares (Direct)
Footnotes (2)
- F1. Mr. Gibson was elected to the Board of Directors on March 3, 2026. Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on March 3rd of each of 2027, 2028, and 2029, provided such Reporting Person continues to serve as a director through the applicable vesting dates.
- F2. One-third of the shares subject to the option will vest on March 3, 2027, which is the one year anniversary of Mr. Gibson joining the Board, and the remainder will vest in equal monthly installments thereafter for 24 months on the same date of the month as his initial start date, provided he continues to serve as a director through each vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did PACB director Christopher Gibson report on March 3, 2026?
Christopher Gibson reported equity awards tied to his PACB board service. He received 73,087 stock options at a $0.00 exercise price and 53,913 shares of common stock in the form of restricted stock units, all recorded as acquisitions rather than open-market purchases.
How many PACB stock options were granted to Christopher Gibson in this Form 4 filing?
Christopher Gibson was granted stock options covering 73,087 PACB shares. One-third of these options vest on March 3, 2027, with the remainder vesting in equal monthly installments over the next 24 months, contingent on his continued service as a director.
What restricted stock unit (RSU) award did PACB grant Christopher Gibson?
PACB granted Christopher Gibson 53,913 shares of common stock represented by RSUs. These RSUs vest in three equal annual installments on March 3 of 2027, 2028, and 2029, provided he continues to serve as a director through each applicable vesting date.
Are Christopher Gibson’s PACB equity awards in this filing open-market purchases?
No, the reported PACB equity awards are not open-market purchases. They are grants classified as acquisitions under transaction code “A,” consisting of stock options and RSUs awarded in connection with Christopher Gibson’s service on the company’s Board of Directors.
When do Christopher Gibson’s PACB stock options begin vesting?
Christopher Gibson’s PACB stock options begin vesting on March 3, 2027. On that date, one-third of the options vest, with the remaining two-thirds vesting in equal monthly installments over the following 24 months, assuming he continues to serve as a director.
What conditions apply to the vesting of Christopher Gibson’s PACB RSUs?
The PACB RSUs granted to Christopher Gibson vest only if he remains a director. They are scheduled to vest in equal annual installments on March 3 of 2027, 2028, and 2029, with each installment requiring continued Board service through its respective vesting date.